STICCHI, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 2.806
NA - Nord America 2.673
EU - Europa 784
SA - Sud America 591
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 117
OC - Oceania 4
Totale 7.136
Nazione #
US - Stati Uniti d'America 2.512
CN - Cina 1.009
SG - Singapore 636
BR - Brasile 449
IT - Italia 369
HK - Hong Kong 301
VN - Vietnam 222
KR - Corea 128
IN - India 94
GB - Regno Unito 85
BD - Bangladesh 84
DE - Germania 79
JP - Giappone 63
FR - Francia 58
IQ - Iraq 58
CA - Canada 54
AR - Argentina 41
FI - Finlandia 39
SA - Arabia Saudita 33
ZA - Sudafrica 33
MX - Messico 30
VE - Venezuela 30
NL - Olanda 26
RU - Federazione Russa 26
TR - Turchia 23
AT - Austria 22
CO - Colombia 22
PK - Pakistan 20
ID - Indonesia 19
ES - Italia 17
EC - Ecuador 16
EG - Egitto 16
JM - Giamaica 16
UZ - Uzbekistan 16
JO - Giordania 14
SE - Svezia 14
AE - Emirati Arabi Uniti 13
MA - Marocco 13
NP - Nepal 12
CR - Costa Rica 11
TN - Tunisia 11
TT - Trinidad e Tobago 11
UA - Ucraina 11
KE - Kenya 10
PL - Polonia 10
UY - Uruguay 9
CL - Cile 8
IL - Israele 8
PY - Paraguay 8
HN - Honduras 7
AZ - Azerbaigian 5
KW - Kuwait 5
NI - Nicaragua 5
OM - Oman 5
PS - Palestinian Territory 5
AU - Australia 4
BB - Barbados 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
IE - Irlanda 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MY - Malesia 4
NG - Nigeria 4
PE - Perù 4
SV - El Salvador 4
BE - Belgio 3
BW - Botswana 3
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
MK - Macedonia 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
AO - Angola 2
BF - Burkina Faso 2
BS - Bahamas 2
BY - Bielorussia 2
GR - Grecia 2
LB - Libano 2
MN - Mongolia 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SR - Suriname 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 6.950
Città #
Shanghai 470
Santa Clara 416
Singapore 370
Hong Kong 283
San Jose 276
Hefei 184
Ashburn 182
Council Bluffs 152
Seoul 128
Los Angeles 124
Boardman 106
Dallas 83
Buffalo 76
Ho Chi Minh City 74
Tokyo 52
Beijing 51
Hanoi 50
São Paulo 40
Rome 37
Milan 33
Pisa 33
Phoenix 30
Dhaka 29
Helsinki 27
Florence 25
Lauterbourg 25
Nuremberg 22
Baghdad 19
New York 19
Atlanta 18
Cascina 18
Haiphong 18
Munich 18
Chicago 17
Tashkent 15
Amman 14
Johannesburg 14
Redondo Beach 14
Rio de Janeiro 14
Denver 13
Frankfurt am Main 13
Naples 13
Bologna 12
Jeddah 12
Mexico City 12
Erbil 11
Massa e Cozzile 11
Belo Horizonte 10
Brasília 10
Düsseldorf 10
Brooklyn 9
Da Nang 9
Fuzhou 9
Istanbul 9
Kingston 9
Nairobi 9
San Francisco 9
Turin 9
Vienna 9
Cape Town 8
Columbus 8
Hải Dương 8
Lappeenranta 8
London 8
Manchester 8
Montevideo 8
Montreal 8
New Delhi 8
Palermo 8
Riyadh 8
Rockville 8
San José 8
Cairo 7
Clarksville 7
Orem 7
Osaka 7
Tunis 7
Baltimore 6
Basra 6
Biên Hòa 6
Curitiba 6
Danville 6
Delhi 6
Genoa 6
Karachi 6
Queens 6
Santo André 6
Surat 6
Baku 5
Buenos Aires 5
Campinas 5
Chennai 5
Dammam 5
Figino 5
Fortaleza 5
Houston 5
Kathmandu 5
Managua 5
Recife 5
Salt Lake City 5
Totale 4.049
Nome #
Illusory Coronary Obstruction After BASILICA: In IVUS We Trust! 258
Drug-eluting balloon in the treatment of in-stent restenosis and diffuse coronary artery disease: Real-world experience from our registry 229
Hemodynamic and Metabolic-Inflammatory Phenotyping Across the Cardiac Index Spectrum in Moderate and Severe Tricuspid Regurgitation: Prognostic Implications 229
Clinical outcomes following bioresorbable scaffold implantation in small vessels 184
Global Prevalence of Mitral Regurgitation: A Systematic Review and Meta-Analysis of Population-Based Studies 174
Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair 136
Transthoracic and transoesophageal echocardiography for tricuspid transcatheter edge-to-edge repair: a step-by-step protocol 134
Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years 129
Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry 127
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 125
Comprehensive insights into peripheral artery disease: an overview from the working groups of pathogenesis of atherosclerosis and thrombosis of the Italian Society of Cardiology 123
Transcatheter Aortic Valve Implantation to Treat Degenerated Aortic, Mitral and Tricuspid Bioprosthesis 122
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 120
Transcatheter Tricuspid Valve Replacement: Current Options and Future Perspectives 118
Optical coherence tomography 118
Gender-Specific Outcomes in TAVI with Self-Expandable Valves: Insights from a Large Real-World Registry 117
Diabetes and mortality in patients with COVID-19: Are we missing the link? 114
Impact of design characteristics among studies comparing coronary computed tomography angiography to noninvasive functional testing in chronic coronary syndromes 111
Correlation Between Voltage and Impedance Mapping in Patients with Atrial Fibrillation 110
Chiusura dell’auricola sinistra: selezione del paziente 109
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 109
Retrograde Retrieval of a Novel Large Mitral Clip After Embolization Into the Left Ventricle 108
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 104
Tricuspid Transcatheter Orthotopic and Heterotopic Replacement Screening F.A.I.L.: First Attempt In Learning! 100
Transseptal Balloon-Assisted Translocation of the Mitral Anterior Leaflet (BATMAN) in Mitral Valve-in-Ring Implantation 100
Heterotopic Transcatheter Tricuspid Valve Implantation: A Useful Bailout Strategy After Failed Transcatheter Tricuspid Valve Repair? 99
Clinical Outcomes After Implantation of Overlapping Bioresorbable Scaffolds vs New Generation Everolimus Eluting Stents [Resultados clínicos tras el implante de armazones bioabsorbibles solapados en comparación con stents liberadores de everolimus de nueva generación] 92
Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery 91
Mitral regurgitation evolution after transcatheter tricuspid valve interventions-a sub-analysis of the TriValve registry 90
Percutaneous Tricuspid Valve Repair 90
Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery 87
Comparison of Mid-Term Prognosis in Intermediate-to-Low-Risk Contemporary Population with Guidelines-Oriented Age Cutoff 86
Use of sirolimus-coated balloon in de novo coronary lesions; long-term clinical outcomes from a multi-center real-world population 80
Mortality benefit with different antithrombotic therapies in patients with stable vascular disease: From pathophysiology to the clinical impact in the real world. The COMPASS study [Beneficio di mortalità delle terapie antitrombotiche in pazienti con malattia vascolare stabile: Dalla fisiopatologia all'impatto clinico e al suo ruolo nel mondo reale. focus sullo studio COMPASS] 79
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 73
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 71
Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population 68
Combined Caval Valved Stent Implantation and Leaflet Approximation for Treatment of Torrential Tricuspid Regurgitation 64
Letter: Completeness or complexity? A nuanced reflection on multivessel revascularisation 61
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients 59
Stress-induced cardiomyopathy related to SARS-CoV-2 59
Clinical outcomes of suboptimal stent deployment as assessed by optical coherence tomography: long-term results of the CLI-OPCI registry 58
Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds 56
Computed tomography analysis of coronary ostia location following valve-in-valve transcatheter aortic valve replacement with the ACURATE neo valve: Implications for coronary access 56
Adoption of a new automated optical coherence tomography software to obtain a lipid plaque spread-out plot 55
Coronary occlusion after valve-in-valve transcatheter aortic valve replacement with bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) in a patient with narrow sinotubular junction 55
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 54
Coronary access following ACURATE neo implantation for transcatheter aortic valve-in-valve implantation: Ex vivo analysis in patient-specific anatomies 53
Dual antiplatelet therapy in coronary artery disease: from the past to the future prospective 51
Expanding our horizons for the use of transcatheter self-expanding valves: what does the future hold? 51
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 51
Vascular approaches and its potential implications in transcatheter aortic valve implantation 50
Functional and Echocardiographic Improvement After Transcatheter Repair for Tricuspid Regurgitation: A Systematic Review and Pooled Analysis 49
Acute Right Ventricular Reshaping After TriClip in Ebstein's-Like Anomaly Assessed by Multimodality Imaging 49
First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: The Milan and New-Tokyo (MITO) registry 49
Rupture of a vulnerable plaque in a hazy angiographic culprit lesion during acute coronary syndrome 48
Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study 47
A Comparison between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience 47
Outcomes After Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Anatomy: A Systematic Review and Meta-Analysis 47
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion 46
Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound 45
Subclinical atrial fibrillation: When to give NAO? 45
Comparison of abluminal biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents in the treatment of coronary bifurcations 44
Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure 44
Short-term outcomes following "full-plastic jacket" everolimus-eluting bioresorbable scaffold implantation 44
Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Replacement: JACC Review Topic of the Week 44
Comparison of first- and second-generation drug-eluting stents in saphenous vein grafts used as aorto-coronary conduits 44
Comparison of results of transcatheter aortic valve implantation in patients with severely stenotic bicuspid versus tricuspid or nonbicuspid valves 44
Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent 44
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 43
Contributors to survival benefit of dual versus single antithrombotic therapy in chronic coronary syndrome: Survival benefit of dual antithrombotic therapy in CCS 42
Biolimus-eluting stent for de-novo coronary artery disease in patients with diabetes mellitus: The BESTFRIENDS multicentre registry 41
Extended follow-up following "full-metal jacket" percutaneous coronary interventions with drug-eluting stents 41
Renal denervation in a patient with two renal accessory arteries: A case report 41
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 41
Iatrogenic aorta-coronary dissection: Case report and systematic review 41
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 41
Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy 40
Reply: Transcatheter Repair for Tricuspid Regurgitation: Ready or Not? 40
The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease 40
The role of everolimus-eluting and resolute zotarolimus-eluting stents in the treatment of coronary bifurcations 40
Thrombus aspiration in primary percutaneous coronary intervention: Still a valid option with improved technique in selected patients! 39
The "hybrid" strategy for complete myocardial revascularization in the frail elderly patient [La strategia "ibrida" per il conseguimento di una rivascolarizzazione miocardica completa nel paziente anziano fragile] 39
First- versus second-generation drug-eluting stents for the treatment of coronary bifurcations 39
Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment 38
Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the corevalve versus the edwards valve 38
Surgical treatment of paravalvular leak: Long-term results in a single-center experience (up to 14 years) 37
Conventional surgery and transcatheter closure via surgical transapical approach for paravalvular leak repair in high-risk patients: Results from a single-centre experience 37
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 37
Acute Tricuspid Valve Remodelling After MitraClip Deployment: Rationale for a Dual-Staged Procedure 36
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 36
Learning From Failure at the CUTTING-EDGE of Transcatheter Mitral Valve Therapies 36
Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club 36
Transcatheter Mitral Valve Replacement for Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Using Balloon-Expandable Transcatheter Heart Valves 36
Patient selection, procedural planning and interventional guidance for transcatheter aortic valve intervention 34
Newly available and recent advances in drug-eluting stents 34
Fractional flow reserve (FFR) as a guide to treat coronary artery disease 31
Immediate and follow-up outcomes of drug-coated balloon angioplasty in de novo long lesions on large coronary arteries 26
Drug-Coated Balloon Percutaneous Coronary Intervention in Diabetic and Non-Diabetic Patients: A Large All-Comers Cohort of Mid-Term Outcomes and Predictors of Adverse Events 9
Totale 7.136
Categoria #
all - tutte 17.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024108 0 0 0 0 0 0 74 0 0 9 2 23
2024/20252.873 55 79 175 41 245 172 502 38 121 161 209 1.075
2025/20263.078 286 374 309 330 361 139 458 161 166 243 91 160
2026/20271.077 120 407 334 216 0 0 0 0 0 0 0 0
Totale 7.136